abstract |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 are as defined herein, and wherein at least one of R 1 , R 2 , R 3 , R 4 or R 5 is F, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. |